Trading Ideas

And no, it has nothing to do with avoiding traditional IRAs or 401(k)s. …read more […]

The upside momentum is likely to continue to rise over the near-term if buyers can sustain a move over $1728.70. …read more […]

While oil price downturns typically create the perfect environment for major mergers and acquisitions, this time may be different …read more […]

(Bloomberg) — PG&E Corp. won final approval of its bankruptcy plan, clearing the way for the California utility giant to emerge from one of the darkest chapters of its history.U.S. Bankruptcy Judge Dennis Montali issued an order Saturday confirming PG&E’s Chapter 11 plan that will cover billions of dollars in damage claims stemming from catastrophic wildfires linked to the company’s equipment. The judge said in an earlier written decision that he planned to approve the turnaround proposal because the alternative would leave tens of thousands of fire survivors with “no other options on the horizon.”PG&E needed the judge to sign …read more […]

* This weekend’s Barron’s cover story at the high cost of income inequality. * Other featured articles look to play the growing tech divide, industrials for the recovery and biotech’s next big run-up. * Also, the prospects for COVID-19 stocks, a boat maker, REITs and more.Cover story “The High Cost of Income Inequality” by Reshma Kapadia suggests that, for stockpickers who always consider long-term trends, it is time to look at economic inequality. What’s in store for the likes of Nike Inc (NYSE: NKE) and Tesla Inc (NASDAQ: TSLA)?Eric J. Savitz’s “How to Profit From the Growing Divide …read more […]

* Benzinga has examined the prospects for many investor favorite stocks over the past week. * This week’s bullish calls included the iPhone maker and an e-commerce giant. * An electric vehicle manufacturer and a steel colossus were among the bearish calls.The main U.S. indexes ended the week higher, led by the Nasdaq’s 3.7% gain. It was a week in which the Federal Reserve began buying corporate bonds for the first time; major corporations responded to social unrest; the Supreme Court issued decisions; and coronavirus cases were rising rapidly in parts of the U.S. While tensions increased …read more […]

This is not your grandmother’s IRA.
In Marc’s latest State of the Market video – which aired on Wealthy Retirement‘s YouTube channel yesterday – he addressed a common misconception that costs too many seniors in retirement…
That diligent savers who want to secure wealth in their golden years don’t have the time to waste on bond investing.
In fact, nothing could be further from the truth.
True, bonds are not the James Dean of the market. They won’t often get your adrenaline pumping like fast-paced options trading…
But they won’t cause inexperienced traders the same gut-wrenching losses, either.
And if you ask readers of Marc’s Oxford …read more […]

It is very likely that Gold has rallied to these current levels as a “global hedge against risk” and that Silver has been overlooked as a secondary asset. …read more […]

Why the Mercedes-Benz AMG G 63 is the ultimate SUV for self-isolation. …read more […]

Market forces rained on the parade of Heat Biologics, Inc. (NASDAQ:HTBX) shareholders today, when the analysts… …read more […]

(Bloomberg) — The Trump administration, following a backlash, said it would release details about companies that received loans of $150,000 or more from a coronavirus relief program for small businesses.Treasury Secretary Steven Mnuchin said last week the firms that got billions of dollars in taxpayer-funded aid wouldn’t be disclosed, sparking fury from Democrats and others. In a joint statement on Friday night, the Treasury Department and the Small Business Administration said the company names, addresses, demographic data and other information would be disclosed in five ranges — starting with $150,000 to $350,000, and going up to between $5 million and …read more […]

The market’s helter-skelter tone is largely reflective of the competing impulses of a nationwide rise in COVID-19 diagnoses and expectations for an economic revival. …read more […]

Luxury RV’s are seeing unprecedented demand. …read more […]

The Forma Therapeutics IPO launched on the Nasdaq market. It hit less than a month after the company filed with the SEC. As biotech companies successfully go public, Forma Therapeutics stock could be the next hit.
But is it a good investment opportunity? Here’s what we know…
Forma Therapeutics IPO: The Business

Forma Therapeutics is a biopharmaceutical company. It aims to develop and commercialize novel therapeutics to help patients with rare hematologic diseases and cancers. The company’s focus is sickle cell disease (SCD) and prostate cancer.
In 2019, Forma reorganized, filing from a limited liability company to a corporation. The company also named Frank …read more […]

One thing we could say about the analysts on Carnival Corporation & Plc (NYSE:CCL) – they aren’t optimistic, having… …read more […]